Inventor · disambiguated record
Jan Heeres
Also filed as: DAEYAERT FREDERIK FRANS DESIRE · HEERES JAN · JANSSEN LEGAL REPRESENTATIVE G
124 granted patents·13 pending applications·2,372 citations·filing 1974–2021
99Inventor score
Files withJANSSEN PHARMACEUTICA NV102GUILLEMONT JEROME EMILE GEORGES4JANSSEN SCIENCES IRELAND UC4HEERES JAN3JANSSEN PHARMACEUTICA INC3
Top patents by PatentIndex Score
137 records- 0198US4267179AHeterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted May 12, 1981·111 cites·7 claims
- 0298US4144346ANovel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazolesJANSSEN PHARMACEUTICA NV·Filed 1977·Granted Mar 13, 1979·79 cites·3 claims
- 0398US3936470A1,3-Dioxolan-2-ylmethylimidazolesJANSSEN PHARMACEUTICA NV·Filed 1975·Granted Feb 3, 1976·40 cites·6 claims
- 0496US7531548B2HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidinesTIBOTEC PHARM LTD·Filed 2005·Granted May 12, 2009·62 cites·18 claims
- 0596US7125879B2HIV inhibiting pyrimidines derivativesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Oct 24, 2006·96 cites·19 claims
- 0696US6197779B1HIV inhibiting pyrimidine derivativeJANSSEN PHARMACEUTICA INC·Filed 1999·Granted Mar 6, 2001·177 cites·4 claims
- 0796US4160838AAntimicrobial and plant-growth-regulating triazole derivativesJANSSEN PHARMACEUTICA NV·Filed 1978·Granted Jul 10, 1979·65 cites·7 claims
- 0896US4079062ATriazole derivativesJANSSEN PHARMACEUTICA NV·Filed 1975·Granted Mar 14, 1978·112 cites·6 claims
- 0995US7514445B2Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)JANSSEN PHARMACEUTICA NV·Filed 2002·Granted Apr 7, 2009·117 cites·8 claims
- 1095US6440986B2HIV Inhibiting pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Aug 27, 2002·74 cites·9 claims
- 1195US4916134A4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolonesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Apr 10, 1990·52 cites·10 claims
- 1295US3991201A1-(β-Aryl-β-R-ethyl)imidazoles as antimicrobial agentsJANSSEN PHARMACEUTICA NV·Filed 1975·Granted Nov 9, 1976·36 cites·14 claims
- 1394US4223036A1-(1,3-Dioxolan-2-ylmethyl)-1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Sep 16, 1980·41 cites·3 claims
- 1492US10611732B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 7, 2020·3 cites·7 claims
- 1592US8153640B2HIV inhibiting bicyclic pyrimdine derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2005·Granted Apr 10, 2012·13 cites·18 claims
- 1692US4791111A[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial propertiesJANSSEN PHARMACEUTICA NV·Filed 1986·Granted Dec 13, 1988·52 cites·25 claims
- 1792US4598085AFungicidal 1-(2-aryl-2-R-ethyl)-1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1982·Granted Jul 1, 1986·57 cites·43 claims
- 1892US4335125A1-(1,3-Dioxolan-2-ylmethyl)-1H-imidazolesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Jun 15, 1982·33 cites·11 claims
- 1992US4156008A1-(4-Alkyl-2-aryl-1,3-dioxolan-2-ylmethyl)-1H-imidazolesJANSSEN PHARMACEUTICA NV·Filed 1976·Granted May 22, 1979·18 cites·9 claims
- 2091US7923554B2HIV inhibiting 1,2,4-triazin-6-one derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 12, 2011·26 cites·25 claims
- 2191US7037917B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 2, 2006·34 cites·32 claims
- 2290US4490540A(2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivativesJANSSEN PHARMACEUTICA NV·Filed 1983·Granted Dec 25, 1984·23 cites·12 claims
- 2390US4338327ASubstituted 1-(2-aryl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Jul 6, 1982·19 cites·11 claims
- 2490US4101665A1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)imidazolesJANSSEN PHARMACEUTICA NV·Filed 1976·Granted Jul 18, 1978·14 cites·6 claims
- 2590US4101666A1-(2-Ar-4-R-1,3-dioxolan-2-ylmethyl)imidazolesJANSSEN PHARMACEUTICA NV·Filed 1976·Granted Jul 18, 1978·15 cites·12 claims
- 2689US10765674B2Prevention of HIV-infectionJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2016·Granted Sep 8, 2020·2 cites·24 claims
- 2789US8003789B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 23, 2011·12 cites·19 claims
- 2889US4931444A5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenolsJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Jun 5, 1990·55 cites·12 claims
- 2988US4619931A[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1984·Granted Oct 28, 1986·31 cites·3 claims
- 3088US4287195AHeterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Sep 1, 1981·17 cites·5 claims
- 3187US6440440B1Biocidal benzylbiphenyl derivativesFiled 1999·Granted Aug 27, 2002·42 cites·12 claims
- 3287US6150360ATrisubstituted 1,3,5-Triazine DerivativesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Nov 21, 2000·62 cites·16 claims
- 3387US4101664A1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)-imidazolesJANSSEN PHARMACEUTICA NV·Filed 1976·Granted Jul 18, 1978·11 cites·4 claims
- 3486US10072015B2HIV inhibiting bicyclic pyrimidine derivativesJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted Sep 11, 2018·2 cites·9 claims
- 3586US8080551B2HIV inhibiting pyrimidines derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2006·Granted Dec 20, 2011·8 cites·39 claims
- 3686US4358449A1-(1,3-Dioxolan-2-ylmethyl)-1H-1,2,4-triazoles and compositionsJANSSEN PHARMACEUTICA NV·Filed 1980·Granted Nov 9, 1982·20 cites·7 claims
- 3786US4139540A2-Aryl-2-halomethyl-4-alkenyl-1,3-dioxolanesJANSSEN PHARMACEUTICA NV·Filed 1977·Granted Feb 13, 1979·8 cites·2 claims
- 3885US7705148B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 27, 2010·7 cites·9 claims
- 3985US7399856B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 15, 2008·19 cites·12 claims
- 4085US7276510B2HIV replication inhibitorsJANSSEN PHARMACEUTICA INC·Filed 2001·Granted Oct 2, 2007·27 cites·49 claims
- 4185US4160841AHeterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazolesJANSSEN PHARMACEUTICA NV·Filed 1977·Granted Jul 10, 1979·13 cites·5 claims
- 4285US3991202AImidazolium saltsJANSSEN PHARMACEUTICA NV·Filed 1974·Granted Nov 9, 1976·16 cites·7 claims
- 4384US7563922B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 21, 2009·6 cites·6 claims
- 4484US7034019B2Prodrugs of HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Apr 25, 2006·14 cites·121 claims
- 4583US9981919B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 29, 2018·2 cites·7 claims
- 4683US8828982B2Pyrimidine derivatives for the prevention of HIV infectionHEERES JAN·Filed 2009·Granted Sep 9, 2014·5 cites·18 claims
- 4783US8530655B2HIV replication inhibiting pyrimidinesCORTE BART DE·Filed 2011·Granted Sep 10, 2013·8 cites·10 claims
- 4882US8026248B2HIV inhibiting pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 27, 2011·4 cites·18 claims
- 4982US5650411ASubstituted azolone derivativesJANSSEN PHARMACEUTICA NV·Filed 1994·Granted Jul 22, 1997·24 cites·14 claims
- 5082US4402957AHeterocyclic derivatives of [4-(piperazin-1-ylphenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1981·Granted Sep 6, 1983·14 cites·2 claims
Showing the top 50 of 137 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jan Heeres files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →